Anti-doping is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
AMM designs have diversified significantly since the early days of the field. A major route is the introduction of bistability to produce molecular switches, featuring two distinct configurations for the molecule to convert between. This has been perceived as a step forward from the original molecular shuttle which consisted of two identical sites for the ring to move between without any preference, in a manner analogous to the ring flip in an unsubstituted cyclohexane. If these two sites are different from each other in terms of features like electron density, this can give rise to weak or strong recognition sites as in biological systems — such AMMs have found applications in catalysis and drug delivery. This switching behavior has been further optimized to acquire useful work that gets lost when a typical switch returns to its original state. Inspired by the use of kinetic control to produce work in natural processes, molecular motors are designed to have a continuous energy influx to keep them away from equilibrium to deliver work. Various energy sources are employed to drive molecular machines today, but this was not the case during the early years of AMM development. Though the movements in AMMs were regulated relative to the random thermal motion generally seen in molecules, they could not be controlled or manipulated as desired. This led to the addition of stimuli-responsive moieties in AMM design, so that externally applied non-thermal sources of energy could drive molecular motion and hence allow control over the properties.
Andy Street, the Mayor of the West Midlands, announces that he and his Manchester counterpart, Andy Burnham, are to meet Mark Harper, the Secretary of State for Transport, to discuss proposals for a privately funded alternative to the abandoned Manchester leg of HS2. The UK is to lend several pieces of the Ghana crown jewels back to Ghana 150 years after looting them from the court of the Asante king. 25 January The UK government announces fresh plans to ban the sale of zombie knives, with legislation taking effect from the autumn. Lloyds Banking Group announces plans to cut around 1,600 positions from its branch staff in a reorganisation that it says is because more customers are banking online. 26 January Buckingham Palace confirms that King Charles III has been admitted to hospital for treatment for an enlarged prostate. Jürgen Klopp, currently the longest-serving manager in the Premier League, announces he is departing as manager of Liverpool F.C. after the conclusion of the 2023–24 season, and taking a break from football management. 27 January The UK government suspends funding for the UN agency for Palestinian refugees, UNRWA, after the organisation sacked several officials reported to have been involved in the 7 October attacks on Israel. Kemi Badenoch, the business secretary, asks Henry Staunton to step down as chair of Post Office Limited after 13 months in the role, as the government moves to strengthen governance at the Post Office in the wake of the long-running Horizon IT scandal.
The disorganised basal cells are seen to be responsible for the major airway changes that are characteristic of COPD, and with continued stress can undergo a malignant transformation. Studies have shown that the initial development of emphysema is centred on the early changes in the airway epithelium of the small airways. Basal cells become further deranged in a smoker's transition to clinically defined COPD.
Newer research has focused on methods of identifying healthier obese people by clinicians, and not treating obese people as a monolithic group. Obese people who do not experience medical complications from their obesity are sometimes called (metabolically) healthy obese, but the extent to which this group exists (especially among older people) is in dispute. The number of people considered metabolically healthy depends on the definition used, and there is no universally accepted definition. There are numerous obese people who have relatively few metabolic abnormalities, and a minority of obese people have no medical complications. The guidelines of the American Association of Clinical Endocrinologists call for physicians to use risk stratification with obese patients when considering how to assess their risk of developing type 2 diabetes. In 2014, the BioSHaRE–EU Healthy Obese Project (sponsored by Maelstrom Research, a team under the Research Institute of the McGill University Health Centre) came up with two definitions for healthy obesity, one more strict and one less so:
Sources: en.wikipedia.org
== History == Some of the most important discoveries relating to transferases occurred as early as the 1930s. Earliest discoveries of transferase activity occurred in other classifications of enzymes, including beta-galactosidase, protease, and acid/base phosphatase. Prior to the realization that individual enzymes were capable of such a task, it was believed that two or more enzymes enacted functional group transfers.
=== Degradation and autolysis === Proteases, being themselves proteins, are cleaved by other protease molecules, sometimes of the same variety. This acts as a method of regulation of protease activity. Some proteases are less active after autolysis (e.g. TEV protease) whilst others are more active (e.g. trypsinogen).
Even though slavery is illegal throughout Africa, forms of modern slavery continue to occur. The 2023 Global Slavery Index, estimated that about 7 million people in Africa were living in conditions of modern slavery, including approximately 3.8 million in forced labour and 3.2 million in forced marriage. Descent-based slavery, in which slave status is inherited, has also continued to be reported in parts of the Sahel, including Mali, Mauritania, Niger, Chad and Sudan..
Sources: en.wikipedia.org
In the 1960s, a character named Chubby Chicken appeared on all Chubby burgers. In 1963, A&W introduced four choices of hamburgers and their corresponding Burger Family members: Papa Burger, Mama Burger, Teen Burger, and Baby Burger. Each burger had a wrapper featuring a cartoon image of the corresponding character. The chain in the United States also used Dennis the Menace as a bespoke mascot in the 1960s, with special comics for the restaurants appearing mainly in print advertising.
Pterophyllum scalare, most commonly referred to as angelfish or freshwater angelfish, is the most common species of Pterophyllum kept in captivity. It is native to the Amazon Basin in Peru, Colombia, and Brazil. Particularly to the Ucayali river in Peru, the Oyapock River in French Guiana, the Essequibo River in Guyana, the Solimões, the Amapá, and the Amazon rivers in Brazil. It is found in swamps or flooded grounds where vegetation is dense and the water is either clear or silty. Its native waters range from a neutral pH of 7.0 down to near 6.0, with a general water hardness (gH) range of 3 to 10 °dH, and water temperature ranging from 26 to 30 °C (75 to 86 °F). This is the species of angelfish most frequently found in the aquarium trade. A similar (cross-breeding possible) P. scalare exists in the Rio Orinoco. They are of the same size and shape, the only difference being the stripes; the Orinoco P. scalare has thinner, but dual, stripes. The diet of Pterophyllum scalare consists of a wide spectrum of prey; they feed on tiny fish fry and younger, juvenile fishes, young and mature shrimps, crabs, prawns, various worms, mosquito larvae, and water bugs. Additionally, they will opportunistically catch any smaller-sized floating insects that have fallen onto the surface of the water.
==== MeSH D13.570.800 – ribonucleosides ==== MeSH D13.570.800.096 – adenosine MeSH D13.570.800.096.250 – adenosine-5'-(n-ethylcarboxamide) MeSH D13.570.800.096.262 – s-adenosylhomocysteine MeSH D13.570.800.096.264 – s-adenosylmethionine MeSH D13.570.800.096.300 – 2-chloroadenosine MeSH D13.570.800.096.300.200 – cladribine MeSH D13.570.800.096.500 – isopentenyladenosine MeSH D13.570.800.096.630 – phenylisopropyladenosine MeSH D13.570.800.286 – cytidine MeSH D13.570.800.286.300 – azacitidine MeSH D13.570.800.330 – dichlororibofuranosylbenzimidazole MeSH D13.570.800.410 – formycins MeSH D13.570.800.410.200 – coformycin MeSH D13.570.800.453 – guanosine MeSH D13.570.800.453.500 – nucleoside q MeSH D13.570.800.573 – inosine MeSH D13.570.800.573.130 – didanosine MeSH D13.570.800.573.450 – inosine pranobex MeSH D13.570.800.573.900 – thioinosine MeSH D13.570.800.573.900.500 – methylthioinosine MeSH D13.570.800.790 – ribavirin MeSH D13.570.800.810 – showdomycin MeSH D13.570.800.840 – toyocamycin MeSH D13.570.800.850 – tubercidin MeSH D13.570.800.892 – uridine MeSH D13.570.800.892.176 – azauridine MeSH D13.570.800.892.250 – 3-deazauridine MeSH D13.570.800.892.628 – pseudouridine MeSH D13.570.800.892.800 – tetrahydrouridine MeSH D13.570.800.892.829 – thiouridine
High-Throughput Protein Laboratory for protein engineering Protein Purification Facilities for small- and large-scale protein production Macromolecular Crystallization & Crystallography Laboratories for solving crystal structures of biological molecules On-site X-ray facility Access to high energy synchrotron radiation at Argonne National Laboratory through the Life Science Collaborative Access Team (LS-CAT)
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.